Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock
We assign a fundamental rating of 4 out of 10 to AKE. AKE was compared to 71 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a bad growth rate and is valued cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.89% | ||
| ROE | 1.76% | ||
| ROIC | 2.77% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.4% | ||
| PM (TTM) | 1.38% | ||
| GM | 18.68% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 17.51 | ||
| Altman-Z | 1.81 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.26 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 10.37 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.31 | ||
| EV/EBITDA | 6.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.92% |
ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.
ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.
The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 214.17%.